FDA Posts Template Updates for Developers of Molecular Diagnostic Tests for Covid-19
The updates address molecular diagnostic tests for pooling patient samples or for screening asymptomatic individuals not suspected of having covid-19.
Read MorePosted by Laurie Bonner | Jun 17, 2020 | Covid 19 |
The updates address molecular diagnostic tests for pooling patient samples or for screening asymptomatic individuals not suspected of having covid-19.
Read MorePosted by Laurie Bonner | Jun 17, 2020 | Covid 19 |
Analysis of data from 16 groups of covid-19 patients highlights the need for expansive testing and contact tracing to mitigate the pandemic.
Read MorePosted by Steve Halasey | Jun 16, 2020 | Covid 19 |
Support from BARDA will help OraSure complete development of its oral fluid diagnostic and file for FDA emergency use authorization.
Read MorePosted by Laurie Bonner | Jun 16, 2020 | Covid 19 |
qPCRbio Probe 1-Step Virus Detect kit is designed specifically for ultra-sensitive, high-throughput detection of viral RNA sequences, including SARS-CoV-2.
Read MorePosted by Laurie Bonner | Jun 16, 2020 | Covid 19 |
Proteins associated with covid-19 are now available to researchers globally for the design and discovery of therapeutics, vaccines, and diagnostic tests.
Read More